LifeVantage Corp. Featured in March's OTC Growth Stock Watch Newsletter

DOVER, MA--(Marketwire - Mar 15, 2012) - OTC Growth Stock Watch newsletter, a publication of OTC Research Corp., today announced new coverage on LifeVantage Corp. (OTCBB: LFVN).

LifeVantage is a science-based nutraceutical company that develops, manufactures and distributes a line of patented dietary supplements and anti-aging cosmetics. The Company's clinically proven formulations reduce oxidative stress, particularly activating the Nuclear factor (erythroid-derived 2) also known as Nrf2, which works on a cellular level. Flagship products include Protandim®, the Nrf2 Synergizer™ patented dietary supplement, and the anti-aging skin care product, TrueScience®. Products are sold in the U.S., Canada, Japan and Mexico through a growing network of independent distributors, preferred customers and direct-to-customers. Dr. Joe McCord, Ph.D., Chief Scientist of LifeVantage, has more than 40 years of research experience in free radical biology, oxidative stress and Nrf2 activation.

About LifeVantage Corporation

LifeVantage, maker of Protandim®, the Nrf2 Synergizer™ patented dietary supplement, is a science based nutraceutical company. LifeVantage is dedicated to visionary science that looks to transform wellness and anti-aging internally and externally with supplements that dramatically reduce oxidative stress at the cellular level. The Company was founded in 2003 with corporate headquarters in Salt Lake City, UT and operations in San Diego, CA. For more information, visit www.LifeVantage.com/beyoungagain

About OTC Growth Stock Watch

Based in Dover, MA, OTC Growth Stock Watch is a publication of OTC Research Corp., published since 1979, OTC Growth Stock Watch has earned its place as one of the most respected and referred-to guides to discovering high-performance growth stocks in the industry. OTCGSW has been regularly referenced by Barrons, Fortune, the Dick Davis Digest, CNBC's Market Mavens and other leading financial news sources.

Geared toward aggressive, growth-oriented investors, OTC Growth Stock Watch reports on companies with a market capitalization under $100 million, which meet a rigid set of financial criteria, niche-oriented products and services, and an annual minimal growth rate of 15%.

To receive the report on LFVN, please go to www.otcgsw.com